Heading to better Process control and Performances

Similar documents
Gumboro symposium 19 th & 20th of January 2012 BUDAPEST. Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE

2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France

Veterinarian Graduated in Brazil and MSc in Preventive Veterinary Medicine Professor of Poultry Disease at University Federal de Minas Gerais

Dr.Christophe Cazaban

«Together we are building a new reference to create value beyond animal health»

Technical meeting 4-6 December 2013 Beijing

Vaccine Application: Experience of a Daily Management. Ceva Poultry Vaccinology Summit-Budapest April 30 th 2015

Implications and implementation of dayold chick vaccination

Ceva s offer to optimize performance Simpler vaccination and better safety

WPSA & WVPA Scientific Conference Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia

ESSENTIAL PROTECTION

investing our GLOBAL RESOURCES FUTURE of in the POULTRY We ll be thereṭm

Public private partnership on a pilot vaccination trial in Egypt

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Vectormune ND a step towards control of Newcastle Disease

Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil

General context and objectives of the project. Public private partnership (PPP) in Veterinary Public Health. EVADOC project Bangladesh Jan-June 2015

Optimization for Chick Performance Bangkok, Thailand 12 th March 2013

PRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between

OIE Situation Report for Highly Pathogenic Avian Influenza

Press Pack. Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection

GUMBORO FIELD EXPERIENCES IN SPAIN THINGS WE HAVE LEARNT!

Short Range Outlook for Steel Demand Autumn OECD Steel Committee, Paris, 10 December Short Range Outlook overview

Control of Gumboro Disease

15th March Hilton Sukhumvit Hotel Bangkok, Thailand

OIE Situation Report for Avian Influenza

Biological monitoring of vaccine take and productive parameters in broilers vaccinated with

Global Cosmetic Dentistry Market Research Report 2018

Evaluation of Biosecurity Status in Commercial Broiler Farms in Sri Lanka

Maximising the benefits of Serological Monitoring and Reporting

OIE Situation Report for Highly Pathogenic Avian Influenza

AviagenBrief. Marek s Disease Control in Broiler Breeders

Vaccination to stop transmission

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

OIE Situation Report for Highly Pathogenic Avian Influenza

Avian Influenza (AI) National & International Update

RECOMBINANT VACCINES Live or Killed

Graduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology.

EPIDEMIOLOGICAL ANALYSIS AND INTERPRETATION OF SERIOUS POULTRY DISEASES

Gumboro Disease: where are we with IBDV epidemiology. J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands

Declaration of a Temporary Control Zone (Avian Influenza)

Merial Vaccination Technologies & Services Equipment Portfolio

USAID s approach to the control of avian and pandemic influenza

VETERINARY SERVICES POLICY STATEMENT

More information at

Summary and Recommendations - APEC Dialogue on Avian Influenza Risks in the Live Bird Market System (LBMS)

How do markets respond to the Avian Influenza outbreaks? The differential impact on market participants: A Case study in Turkey

Exploring Investments in Meat and Poultry Plants in the USA

AN EGG ECONOMICS UPDATE

Update to Iowa Foot and Mouth Disease (FMD) and Livestock Emergency Management Plans

Tobacco Insights May

Innovations in Halal Logistics

Hot Topics In Preparedness. Lessons Learned in Business Continuity

Global EHS Resource Center

Review of Vaccine and Vaccination Component in Global Avian Influenza Control Strategies

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018

For personal use only

CONVENIENCE PROGRAM. An early start in respiratory health for a more profitable life.

Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( )

I N T R O D U C T I O N

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

Avian Influenza 2003 A six months experience 21 October Ben Dellaert

Regional Overview of the implementation of National Control Strategies for Avian Influenza. Summary review of questionnaire OIE RRAP

Global Polybutylene Terephthalate (PBT) Market Study ( )

MARKET NEWS for pig meat

The Cigarette Market in Saudi Arabia

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures

Egypt Success Story In Combating Avian Influenza

OIE Situation Report for Avian Influenza

List of third countries that impose import restrictions to EU products concerning Avian Influenza - HPAI (H5N8) EU MS affected: DE, IT, NL and UK

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Global Terephthalic Acid (PTA) Market Study ( )

CEVAC CEVAC BROILER ND K / 5000 doses

OIE Situation Report for Avian Influenza

2Q 2017 Ceramic Tile Industry Update

China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020

Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research

New Zealand Government Oversight of Halal Certification of Animal Products Exported from New Zealand Auckland University Asia Dialogue July 2012

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

Is Newcastle disease still a threat for the poultry industry?

Towards a Sustainable Global Infrastructure for Medical Countermeasures

Essential Oil & Aromatherapy Market Research Report- Forecast to 2023

Asia s Diabetes Challenge

Weight Loss and Weight Management - Global Market Outlook ( )

Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology &

MG and MS Control in Layers

EU5 Bariatric Surgery Procedures Outlook to 2020

African swine fever in the EU 13/10/16 EP

Commercial chicken vaccination: part 1 spray and aerosol usage

3. What factors influence your decision when determining the duration of use?

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation

MEDIA KIT. 27th Annual Conference Sponsorship Opportunities. Society of Clinical Research Associates. Clinical Research Certification

Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022

FMD Control Initiatives in Bangladesh

Mexico Ostomy Drainage Bags Market Outlook to 2020

California Custom Processing Plant Quality Assurance Plan

OIE Situation Report for Avian Influenza

Industry Perspective: Strategies and costs associated with increasing seasonal influenza vaccine. since 2006

State of U.S. Egg Layer Health 2013 Annual Survey

Transcription:

Dr Sylvain Comte Dr. Comte graduated as veterinarian in 1993 be The National of Veterinary School of Nantes (France). Master of Sciences in Physiology and Agronomy be Rennes University (France). He started his professional carrier in Veterinary Services for Rural Development. He joined Ceva in 1998 and since there he has held various positions. Today, Dr Sylvain is the Poultry Corporate Marketing Director - Executive Director. He is in charge of Global Strategy and Business development for Vaccines and Pharmaceuticals for Poultry Innovation in Vaccination Hatchery Practices: Heading to better Process control and Performances Dr Sylvain Comte Poultry Corporate Marketing Director Hatchery Innovation Summit June 3rd 2014 Nusa Dua Bali, Indonesia 1

Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives 2

1 Tomorrow s Poultry Producers needs? Ceva Survey 2013 Pressures, Plans and Problems of poultry producers 30 Large Broiler Producers Representing: 24% of the Global 2013 Broiler production Belonging to the Top10 in their country Belonging to the Top 100 at global level Geographical coverage: USA, Mexico, Brazil, Peru China, Thailand, Indonesia, Philippines, Russia, Turkey, Spain South Africa, Egypt, Saudi Arabia, Interviews and analysis carried out by Ceva Account managers and Customer contacts at national level. 3

3 Questions to Poultry Producers CEO / Production managers / Animal Health Managers 1. What PRESSURES do you presently face from an Economic, Social and Poultry market Context? 2. What PLANS do you have to cope with these Pressures? 3. What PROBLEMS do you face in implementing these Plans? Producer Survey 2013 - Results Synthesis PRESSURES High Disease challenge High Feed cost Increasing Market Competition - Price pressure PLANS Increase Vaccination & Biosecurity Customized Vacc. Program per Zone or Season Investigate new production process & organization PROBLEMS Failure in disease control & production performances Lack of expertise & Internal knowledge Organization complexity & Internal alignment 4

Producer Survey 2013 - Results Synthesis Disease challenge Economic constraint Prevention Optimization Process Innovation New tools & approaches Simplified Management Support & Staff Training Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives 5

Vaccination Quality 16-Oct 23-Oct 30-Oct 06-Nov 13-Nov 20-Nov 21-Nov 01-déc 11-Dic 12-Dic 18-Dic 30-Dic 15-Ene 29-Ene 10-Feb 3/6/2014 Labor 1 - HUMAN and Vaccination FACTOR Process Management Control Hatchery A dedicated team : MAXIMISED work control Broiler houses Thousands of farmers and field conditions : LIMITED work control 1 - HUMAN FACTOR Process Control Vaccinator A 100% 95% 90% 96,33% 99,00% 93,00% 98,67% 95,33% 96,40% 98,50% 98,00% 95,90% 98,33% 98,67% 97,25% 85% 80% 82,00% 84,00% Sub-Cutaneous Injection 75% 70% 65% 60% Dates of Audits Carlos.gonzalez@ceva.com 6

2 - EQUIPMENT Process control 2 - EQUIPMENT Process control Desvac IN LINE SPRAY 7

2 - EQUIPMENT Process control Spray Vaccination Vaccination/Disease VMD (microns) Color Nozzle Booster 115 Inox TXSS2 IB Primer 153 Red TXVK6 ND primer 173 Grey TXVK8 Primer IB /ND (warm country ) 235 Orange TXVK18 3 VACCINE PREPARATION Process control Carlos.gonzalez@ceva.com 8

with a good day old chick HOMOGENEITY OF VACCINATION PERFORMANCE Immune complex IBD (SQ) 100 % Positive flocks Immune complex IBD (in ovo) 99.3 % Positive flocks Drinking water IBD 70 % Positive flocks Gumboro Elisa at slaughter SPAIN 2011 9

Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives Hatchery Injection Practices - 2012 10

New Technology vaccines at Hatchery Immune Complex & Vector HVT Vaccines rhvt Global usage of New Technology Vac.: From 15 % to 51 % between 2008 and 2013 New Technology Vaccines at Hatchery 2008 : 15 % of Global Broiler Prod. 10% 1% 3% 0% 85% IBD New Tech. Vacc. ND New Tech. Vacc. LT New Tech. Vacc. AI New Tech. Vacc. Conventional New Technology Vaccines at Hatchery 2013 : 51 % of Global Broiler Prod. IBD New Tech. Vacc. % of Global Yearly Broiler Production 49% 35% ND New Tech. Vacc. LT New Tech. Vacc. AI New Tech. Vacc. 11% Conventional 1% 4% 11

Usage against IBD : From 12 % to 35% between 2008 and 2013 IBD New Technology Vaccines 2008 : 12 % of Global Broiler Prod. 6% 4% Immune Complex IBD 90% Vector HVT IBD Conventional IBD IBD New Technology Vaccines 2013: 35% of Global Broiler Prod. % of Global Yearly Broiler Production 17% Immune Complex IBD 65% 18% Vector HVT IBD Conventional IBD Usage against ND and LT: From 4% to 15% between 2008 and 2013 ND / LT - New Technology Vaccines 2008 : 4 % of Global Broiler Prod 1% 2% 1% Vector HVT ND Vector HVT LT ND / LT - New Technology Vaccines 2013: 15 % of Global Broiler Prod 96% Vector FP LT Conventional ND and LT 11% 3% 1% Vector HVT ND Vector HVT LT % of Global Yearly Broiler Production 85% Vector FP LT Conventional ND and LT Vector HVT ND are leading the growth in ND control 12

Main suppliers of New Technology vaccines New Technology Vaccines 2013 : % Yearly Broiler Production Per Company 27% Ceva Supplier A 49% Supplier B 17% Supplier C Conventional 2% 6% Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives 13

Conclusion Hatchery vaccination brings more than a better Vaccination It changes the Poultry Production process: * Allowing a better process control * Simplifying management * Relieving organization and farmers from a number of field vaccinations, * Freeing time for essential activities related to rearing management. Thanks for your attention! 14